Fetal cerebral ventricular atria width of 8-10mm: A possible prenatal risk factor for adolescent treated Attention Deficit Hyperactivity Disorder (ADHD).
A “normal” 8–10 mm fetal brain fluid space quietly doubles later ADHD and stimulant risk.
01Research in Context
What this study did
Doctors saved routine prenatal ultrasound pictures. They looked at the width of the fluid spaces inside the fetal brain. These spaces are called the ventricular atria.
They compared kids who later got ADHD and needed stimulant pills with kids who did not. The kids were about 13 years old at follow-up.
What they found
Kids whose atria measured 8–10 mm in the womb had 2.6 times higher odds of ADHD diagnosis and stimulant use in middle school.
That size range is still labeled “normal” on most ultrasound reports, so parents are usually told everything looks fine.
How this fits with other research
Boets et al. (2011) and Stewart et al. (2018) tried the same idea with head size and autism. They found no clear link, but Zvi et al. now show a link for ADHD with a different brain measure. The story depends on which marker and which diagnosis you track.
Balaum et al. (2026) found that extreme head growth after birth predicts ASD. Zvi’s finding is similar: a quiet early marker can flag later risk, but the timing and the condition differ.
Taken together, the papers say one size does not fit all. Fetal atria width seems to matter for ADHD, while head circumference matters more for ASD.
Why it matters
You can’t change brain ventricles, but you can watch kids who had that 8–10 mm finding. Tell parents to mention the prenatal report at well-child visits. If attention problems show up, you can start assessment sooner and explain why stimulant treatment might be on the table.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Check intake forms for prenatal ultrasound notes; flag any 8–10 mm atria width for closer ADHD screening.
02At a glance
03Original abstract
The purpose of our research was to study the in-utero and long term post-natal outcome of fetal isolated cerebral ventricular atria width between 8 and 10mm. We conducted a retrospective, observational, case-control study, of low risk pregnant women, between 1993 and 2001. One hundred and forty one fetuses with isolated cerebral ventricular atria width between 8 and 10mm, corresponding to 2-4 standard deviations above the mean, and 309 controls, with atrial width below this level, were included for the analysis. Clinical data concerning pre and post-natal outcome was retrieved from computerized medical records. Matching of cases with controls was based on age, with a ratio of 2-3 controls per case. Statistical analysis included: T-test, Chi-Square, and Multiple Logistic Regression analysis. The study group was characterized by a predominance of male gender, left side involvement, and higher birth weight, compared to the control group. Long term post-natal follow-up at a mean age of 12.7 years (±1.9) demonstrated an adjusted odds ratio of 2.589 (95% CI 1.415-4.737, p=0.001), being diagnosed as Attention Deficit Hyperactivity Disorder (ADHD), and treated by Methylphenidate (Ritalin(®)), during childhood, compared to the control group (23.6% and 10.0% respectively) (p=0.001). Cerebral atria width was an independent factor, controlled for the only two significant variants between groups, gender and weight over 90th centile. In conclusions, our preliminary results show that fetuses with prenatal finding of isolated cerebral ventricular atria width between 8 and 10mm are more likely of being diagnosed and treated as ADHD during childhood.
Research in developmental disabilities, 2016 · doi:10.1016/j.ridd.2015.11.008